Boston mesothelioma attorney blog Tag Archives

April 23, 2017

Immunotherapy as Possible Treatment for Malignant Mesothelioma

While we often hear people talk about how some types are worse than others, it basically doesn’t get much worse than malignant mesothelioma. Mesothelioma is virtually always caused when a victim is exposed to deadly asbestos fibers. The fibers become embedded in a layer of protective tissue known as the mesothelium, where they can metastasize into the deadly form of cancer known as mesothelioma.

The reason mesothelioma is so horrific is because only 10 percent of patients on average each year are diagnosed before the cancer has fully has metastasized. For the other 90-plus percent of mesothelioma victims, the cancer is already in stages one through four, and there is no cure and are not very many effective treatment options. To get an idea of how serious malignant mesothelioma is, most patients will be dead within one year of receiving an initial diagnosis. Continue reading

February 14, 2017

Treating Mesothelioma and Other Asbestos-Related Cancers

by Jeffrey S. Glassman

There is no cure for mesothelioma. Sadly, when most people first learn they have malignant mesothelioma, they are often told they only have a very short time left to live.

While there is nothing close to a cure, there are several treatment options available. However, there is often somewhat of a mixed bag, and many patients may elect not to undergo these treatment procedures. The reason for is because they are not very effective in terms of stopping or reversing tumor growth, and they can be very invasive. Continue reading

August 1, 2016

Dummitt v. Crane Co. – Duty to Warn of Asbestos Exposure

by Jeffrey S. Glassman

We know that manufacturers of products sold in the U.S have a duty to warn consumers of potential risks. This is certainly true with makers of asbestos-laden products, particularly where users are at risk of exposure to deadly asbestos fibers or dust, which are toxic when breathed in.

But what duty do makers of non-asbestos products have to warn when there are asbestos-containing parts that are made by a third party but used in its non-asbestos product?

Recently, the New York Court of Appeals – the highest court in that state – took on this issue in Dummitt v. Crane Co. Continue reading